Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Kanmin Xue has won the Ruskell Medal from the Worshipful Company of Spectacle Makers

Kanmin Xue receiving a medal from two men © WCSM/Mark Witter Photography

Kanmin Xue from our Clinical Ophthalmology Research Group won the award for a publication in Nature Medicine: Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia.

This paper provides the complete results of the world's first phase I/II study of retinal gene therapy for choroideremia, an important inherited cause of blindness. By demonstrating sustained preservation or improvement in visual acuity in the treated eyes over 2 to 5 years, the results led to the largest international multi-centre phase III trial of gene therapy to date, and helped to establish the protocols for evaluating changes in visual function and retinal anatomy in future retinal gene therapy trials. 

The medal was presented at a ceremony at the Worshipful Society of Apothecaries in London by The Master & Professor John Marshall (pictured with Kanmin above).

Kanmin Xue returns to our Department in January 2020 on a Wellcome Trust Clinical Research Development Fellowship and will set up his own research group.

 

Similar stories

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.